Keywords: aventis, canadian, unit, fined, price-fixing, methylglucamine, subsidiary

Aventis' Canadian unit fined for price-fixing on methylglucamine

Article | 10 March 2003

Aventis' Canadian subsidiary Rhone-Poulenc Biochemie has been finedC$500,000 ($335,700) after pleading guilty to a charge of price-fixing, in collusion with Merck ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aventis

Aventis Pharma

Merck

Merck KGaA

Go to company listing